C5 inhibition is a proven therapeutic target with several monoclonal antibody (mAb) and small molecule drugs in the clinic. To explore alternative modes of inhibition, novel C5-blocking mAbs were generated and compared to therapeutic mAbs eculizumab and croval... ...

请注册登录后继续浏览